5 unchanged sentences
Purchases of Equity Securities by the Issuer
−Removed: On October 30, 2013, the Company's Board of Directors (the "Board") approved an equity repurchase program (the “Repurchase Program”) authorizing the repurchase of up to $125 million of our common stock.
−Removed: The Board increased the stock repurchase authorization under the Repurchase Program with respect to the repurchase of the Company's common stock by $600 million, $1.5 billion, $2.0 billion, $1.5 billion, $2.0 billion, and $2.0 billion in 2015, 2016, 2017, 2018, 2019, and 2022, respectively.
−Removed: On July 31, 2023, the Board increased the stock repurchase authorization under the Repurchase Program by an additional $2,000 million, which increased the total amount that has been authorized under the Repurchase Program to $11,725 million.
+Added: On October 30, 2013, our Board of Directors (the "Board") approved an equity repurchase program (the “Repurchase Program”) authorizing the repurchase of up to $125 million of our common stock.
+Added: The Board increased the stock repurchase authorization under the Repurchase Program with respect to the repurchase of our common stock by $600 million, $1.5 billion, $2.0 billion, $1.5 billion, $2.0 billion, $2.0 billion, and $2.0 billion in 2015, 2016, 2017, 2018, 2019, 2022, and 2023, respectively, which increased the total amount that has been authorized under the Repurchase Program to $11,725 million.
The Repurchase Program does not obligate us to repurchase any particular amount of common stock, and it may be modified, extended, suspended or discontinued at any time.
3 unchanged sentences
In addition, from time to time, we have repurchased and may continue to repurchase common stock through private or other transactions outside of the Repurchase Program.
−Removed: From inception of the Repurchase Program through September 30, 2023, we have repurchased a total of $9,133 million of our securities under the Repurchase Program.
−Removed: During the nine months ended September 30, 2023, we repurchased 3.9 million shares of our common stock for $763 million under the Repurchase Program.
+Added: From inception of the Repurchase Program through March 31, 2024, we have repurchased a total of $9,362 million of our securities under the Repurchase Program.
+Added: During the three months ended March 31, 2024, we did not repurchase any shares of our common stock under the Repurchase Program.
See Note 9 to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for additional details regarding the Repurchase Program.
−Removed: As of September 30, 2023, we had remaining authorization to repurchase up to $2,592 million of our common stock under the Repurchase Program.
+Added: As of March 31, 2024, we had remaining authorization to repurchase up to $2,363 million of our common stock under the Repurchase Program.
Since the merger between Quintiles and IMS Health, we have repurchased 78.1 million shares of our common stock at an average market price per share of $115.02 for an aggregate purchase price of $8,988 million both under and outside of the Repurchase Program.
−Removed: This includes shares withheld from employees to satisfy certain tax obligations due in connection with grants of stock under the Quintiles IMS Holdings, Inc.
+Added: This includes shares withheld from employees to satisfy certain tax obligations due in connection with grants of stock under the IQVIA Holdings, Inc.
2017 Incentive and Stock Award Plan (the “Plan”).
2 unchanged sentences
The shares of common stock withheld to satisfy tax withholding obligations may be deemed to be “issuer purchases” of shares that are required to be disclosed pursuant to this Item.
−Removed: The following table summarizes the monthly equity repurchase program activity for the three months ended September 30, 2023 and the approximate dollar value of shares that may yet be purchased pursuant to the Repurchase Program.
+Added: The following table summarizes the monthly equity repurchase program activity for the three months ended March 31, 2024 and the approximate dollar value of shares that may yet be purchased pursuant to the Repurchase Program.
(in millions, except per share data) Total Number of Shares Purchased Average Price Paid Per Share Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs
−Removed: July 1, 2023 — July 31, 2023 — $ — — $ 2,736
−Removed: August 1, 2023 — August 31, 2023 0.4 $ 214.65 0.4 $ 2,647
−Removed: September 1, 2023 — September 30, 2023 0.3 $ 205.63 0.3 $ 2,592
+Added: January 1, 2024 — January 31, 2024 — $ — — $ 2,363
+Added: February 1, 2024 — February 29, 2024 — $ — — $ 2,363
+Added: March 1, 2024 — March 31, 2024 — $ — — $ 2,363
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.